期刊文献+

阿尔茨海默病的免疫治疗

Amyloid-β immunotherapy for Alzheimer's disease
暂未订购
导出
摘要 阿尔茨海默病(AD)是一种最常见的老年期痴呆综合征,其特征性的病理改变之一是β淀粉样蛋白(Aβ)为核心的老年斑。减少Aβ被认为是AD治疗的主要靶向之一,而针对Aβ的免疫疗法也已成为当今AD研究的一大主题。该文就AD免疫疗法的类型、并发症、影响疗效的因素等方面的研究进展作一综述。 Alzheimer's disease (AD) is the most common form of dementia among the elderly. Plaques containing β-amyloid ( Aβ) protein are one of the pathological features of AD, and the reduction of Aβ is considered as a prima-ry therapeutic target. Aβ immunotherapy is an evolving approach to the treatment of Alzheimer's disease now. In this article, we will review active and passive immunization against Aβ and the studies related to AD immunotherapy.
出处 《上海第二医科大学学报》 CSCD 2004年第8期683-687,共5页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 阿尔茨海默病 免疫治疗 AD 老年期 痴呆综合征 Β淀粉样蛋白 Alzheimer's disease β-amyloid protein immunotherapy
  • 相关文献

参考文献30

  • 1Schenk D. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning[J]. Nat Rev Neurosci, 2002,3: 824-828.
  • 2Selkoe DJ. Deciphering the genesis and fate of amyloid beta- protein yields novel therapies for Alzheimer disease[J]. J Clin Invest, 2002,110: 1 375-1 381.
  • 3Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid beta attenuates Alzheimer- disease-like pathology in the PDAPP mouse[J]. Nature, 1999,400: 173-177.
  • 4Janus C, Pearson J, McLaurin J, et al. Abeta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease[J]. Nature, 2000,408: 979-982.
  • 5Morgan D, Diamond DM, Gottschall PE, et al. Abeta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease[J]. Nature, 2000,408: 982-985.
  • 6Bard F, Cannon C, Barbour R, et al. Peripherally administered antibodies against amyloid beta- peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease[J]. Nat Med, 2000,6: 916-919.
  • 7DeMattos RB, Bales KR, Cummins DJ, et al. Peripheral anti -Abeta antibody alters CNS and plasma Abeta clearance and decreases brain Abeta burden in a mouse model of Alzheimer's disease[J]. Proc Natl Acad Sci USA, 2001,98: 8 850-8 855.
  • 8DeMattos RB, Bales KR, Cummins DJ, et al. Brain to plasma amyloid -beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease[J]. Science, 2002,295: 2 264-2 267.
  • 9Check E. Nerve inflammation halts trial for Alzheimer's drug[J]. Nature, 2002,415: 462.
  • 10Bishop GM, Robinson SR, Smith MA, et al. Call for Elan to publish Alzheimer's trial details[J]. Nature, 2002,416: 677.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部